Searched for
METROPOLIS HEALTHCARE SHARES
Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...- Last date to buy these four stocks for dividends. Do you own any?Investors have a final chance today, May 18, to purchase shares of Alicon Castalloy, Atishay, Man InfraConstruction, and Metropolis Healthc...
- Dividends, stock splits: L&T, Havells among 15 stocks turning ex-date this week. Check detailsInvestors should note upcoming corporate actions. Several companies including GM Breweries, Havells India, and Larsen & Toubro will turn ex...
- Bonus issue alert: This smallcap stock goes ex-bonus for a 3:1 issue this week. Do you own?Metropolis Healthcare's shares will trade ex-record date for its 3:1 bonus issue on Friday, meaning only shareholders holding the stock by ...
- Metropolis Healthcare shares jump over 4% as revenue surges 23% YoY in Q2 updateMetropolis Healthcare shares: As per its Q2FY26 business update, consolidated growth was driven by strong demand for preventive health chec...
- Stock Radar: Metropolis Healthcare breaks out from 2-month consolidation; likely to retest 2,000 levelsMetropolis Healthcare Ltd. experienced a breakout from a 2-month consolidation in July 2025, signaling potential for further upward movemen...
- Metropolis Healthcare Q4 Results: Profit dips 19% to Rs 29 croreMetropolis Healthcare on Tuesday said its consolidated net profit declined 19 per cent to Rs 29 crore in the fourth quarter ended March qua...
- I-Sec upgrades Metropolis Healthcare to Buy, lowers target price to Rs 2,250ICICI Securities has upgraded Metropolis Healthcare to Buy, setting a target price of Rs 2,250. The company reported a net profit of Rs 31....
- Add Metropolis Healthcare, target price Rs 2,335: ICICI SecuritiesICICI Securities maintains an Add rating on Metropolis Healthcare with a raised target price of Rs 2,335. Metropolis is acquiring Core Diag...
- Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crMetropolis will acquire a 100% stake in Core Diagnostics financing Rs 135.76 crores or 55% in cash and the rest Rs 111.07 through an equity...
- Buy Metropolis Healthcare, target price Rs 1420: Sharekhan by BNP ParibasMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6849.87 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1775: JM FinancialMetropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...
- Buy Metropolis Healthcare, target price Rs 1978: BNP Paribas SecuritiesPromoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.
- Buy Metropolis Healthcare, target price Rs 1735: Yes SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7804.15 Crore) operating in Hosp...
- Buy Metropolis Healthcare, target price Rs 2187: ICICI SecuritiesMetropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 7811.42 Crore) operating in Hosp...
- Metropolis Healthcare up 0.7% as board approves acquisition of Hitech DiagnosticMetropolis Healthcare said the deal would be worth Rs 636 crore.
- Metropolis Healthcare Q1 results: Co posts net profit at Rs 75 crConsolidated revenue from operations of the company stood at Rs 326.76 crore for the quarter under consideration. It was Rs 143.12 crore fo...
- Metropolis Healthcare jumps 9% as Q4 profit multipliesIn Q4, the company recorded its highest ever quarterly revenue largely led by a healthy recovery in non-Covid and increased Covid testing o...
- Buy Metropolis Healthcare, target price Rs 1,466: ICICI SecuritiesThe recent correction in stock price has made the valuations reasonable.
- Metropolis Healthcare gains 9% on market debutThe Rs 1,204 crore IPO, which was sold between April 3 to April 5, was subscribed 5.83 times.
Load More
